TRIPLE ACTIVATOR ACTIVATING GLUCAGON, GLP-1 AND GIP RECEPTOR

Title:

TRIPLE ACTIVATOR ACTIVATING GLUCAGON, GLP-1 AND GIP RECEPTOR

Document Type and Number:

WIPO Patent Application WO/2017/116204

Kind Code:

A1

Abstract:

The present invention relates to a triple activator which activates glucagon, GLP-1 and GIP receptor and to the applications of the triple activator.

More Like This:

WO/2021/010532	METHOD FOR PREPARING LONG-ACTING DRUG CONJUGATE THROUGH PREPARATION OF NOVEL INTERMEDIATE
JP2024500343	Use of GLP-2 analogs in patients with renal failure
WO/2014/077801	PURIFICATION PROCESS FOR PREPARING HIGHLY PURE TASPOGLUTIDE

Inventors:

OH EUH LIM (KR)
LEE JONG SUK (KR)
PARK YOUNG JIN (KR)
LIM CHANG KI (KR)
JUNG SUNG YOUB (KR)
KWON SE CHANG (KR)

Application Number:

PCT/KR2016/015554

Publication Date:

July 06, 2017

Filing Date:

December 30, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HANMI PHARM IND CO LTD (KR)

International Classes:

C07K14/605; A61K38/26

Domestic Patent References:

WO2004093823A2

2004-11-04

Foreign References:

US20130203659A1	2013-08-08
US20120329715A1	2012-12-27
KR20140018462A	2014-02-13

Other References:

DRUCKER ET AL.: "The Incretin System: Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes", THE LANCET, vol. 368, no. 11, 2006, pages 1696 - 1705, XP027947354
See also references of EP 3398961A4

Attorney, Agent or Firm:

SON, Min (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND APPARATUS FOR SUPPORTING FOREIGN LANGUAGE READING COMPREHENSION

Next Patent: PERSISTENT CONJUGATE OF TRIPLE ACTIVATOR ACTIVATING GLUCAGON, GLP-1 AND GIP RECEPTOR